Mucolik (carbocysteine) syrup 2% 125 ml. vial


Treatment of symptoms of violations of bronchial secretion and sputum excretion, especially in acute bronchopulmonary diseases, such as acute bronchitis; in exacerbations of chronic diseases of the respiratory system.



Mucolik composition
active substance: carbocisteine;
Mucolik 2%: 1 ml of syrup contains 20 mg of carbocisteine;
excipients: methyl parahydroxybenzoate (E 218), sucrose, glycerin, sodium hydroxide, Banana flavor (contains propylene glycol), sunset yellow FCF (E 110), purified water.

Release form
The drug is sold in the form of a syrup, in bottles of 125 ml.

Pharmacological properties
Mucolik belongs to the group of expectorant herbal medicines that are used in the treatment of colds in which a cough is observed.
The active ingredient of the drug is carbocisteine.
Reduces inflammation in the throat, helping to relieve dry coughs that irritate the mucous walls.
It works as a mucolytic, interfering with the work of the gel phase of mucus secretion by the respiratory tract, and breaks glycoprotein disulfide bridges. As a result, an excessively viscous secretion in the bronchi liquefies, which stimulates the excretion of sputum from the respiratory system.
Carbocisteine ​​has the property of normalizing the amount of acidic and neutral sialomucins circulating in the bronchial secretion, making it less viscous and more elastic.
It causes regeneration in the mucous membranes of the respiratory system, promotes its structural normalization, and reduces the production of mucous secretions.
Reduces puffiness, has anti-inflammatory effect.
In general, the drug relieves coughing, facilitates breathing, accelerates recovery from colds.

Mucolik is used in the complex therapy of inflammatory diseases of the respiratory tract, accompanied by dry, unproductive cough, relieves inflammation, improves sputum discharge.
In particular, it is used in the treatment of:

  • acute and chronic bronchitis;
  • bronchopneumonia;
  • pharyngitis, laryngitis.

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components.
It is also contraindicated for use with stomach ulcers and duodenal ulcers.
It is not recommended to use it together with antitussives.

In pediatrics, Mucolik 2% is used from 2 years of age.

Application during pregnancy and lactation
This drug is contraindicated for pregnant women.
If it is necessary to take the drug during breastfeeding, lactation is suspended.

Method of administration and dosage
The drug Mucolik is used in the treatment of colds in the respiratory tract.
Recommended dosages:

  • children from 2 to 5 years – 2% drug, 5 ml (1 tsp) 2 times a day;
  • children from 5 to 15 years old – 2% drug, 5 ml 2 times a day;
  • adults and children over 15 years old – 5% drug, 15 ml (3 teaspoons or 1 tablespoon) 3 times a day.

The duration of treatment is no more than 8-10 days, for children under 15 years old – no more than 5 days and 100 mg of carbocisteine ​​per day.
Patients with renal or hepatic insufficiency do not need dosage adjustment.
The patient should consult a doctor if the symptoms of the disease did not disappear during the use of the drug or if adverse reactions are observed that are not indicated in the instructions for medical use of the drug.

Overdose can cause dyspeptic symptoms – nausea, vomiting, diarrhea, abdominal pain.
Treatment of symptoms should be undertaken, gastric lavage, enterosorbents should be taken.

Side effects
The use of this drug can cause side effects, in particular:

  • allergic urticaria, itching, rash;
  • nausea, vomiting, diarrhea, angioedema, bronchospasm;
  • peripheral edema, shortness of breath, headache;
  • cough.

If side effects occur, the drug should be discontinued, symptomatic therapy should be undertaken, consult a doctor and the treatment regimen should be adjusted.

Storage conditions and periods
Shelf life is 2 years. After opening the bottle, the shelf life is 1 year.
The storage temperature should not exceed 25 ° C.